159 related articles for article (PubMed ID: 29171473)
1. [Time course of changes in cytokines (IFN-γ, IFN-α, IL-18, TNF-α) in the treatment of moderate influenza A (H1N1) pdm09 (2013-2016) with oseltamivir (Tamiflu) and umifenovir (Arbidol) alone and in combination with Kagocel].
Popov AF; Simakova AI; Dmitrenko KA; Shchelkanov MY
Ter Arkh; 2017; 89(10):66-70. PubMed ID: 29171473
[TBL] [Abstract][Full Text] [Related]
2. Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010-2011 influenza season in Russia.
Leneva IA; Burtseva EI; Yatsyshina SB; Fedyakina IT; Kirillova ES; Selkova EP; Osipova E; Maleev VV
Int J Infect Dis; 2016 Feb; 43():77-84. PubMed ID: 26775570
[TBL] [Abstract][Full Text] [Related]
3. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
4. Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
Kang SJ; Park KH; Kee SJ; Shin JH; Jung SI; Kwon YS; Jang HC
Jpn J Infect Dis; 2013; 66(5):425-7. PubMed ID: 24047743
[TBL] [Abstract][Full Text] [Related]
5. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.].
Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI
Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059
[TBL] [Abstract][Full Text] [Related]
6. Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.
Liu Q; Xiong HR; Lu L; Liu YY; Luo F; Hou W; Yang ZQ
Acta Pharmacol Sin; 2013 Aug; 34(8):1075-83. PubMed ID: 23770981
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).
Pshenichnaya NY; Bulgakova VA; Lvov NI; Poromov AA; Selkova EP; Grekova AI; Shestakova IV; Maleev VV; Leneva IA
Ter Arkh; 2019 Mar; 91(3):56-63. PubMed ID: 31094461
[TBL] [Abstract][Full Text] [Related]
8. Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice.
Lai YN; Li Y; Fu LC; Zhao F; Liu N; Zhang FX; Xu PP
J Med Virol; 2017 Jul; 89(7):1158-1167. PubMed ID: 27966790
[TBL] [Abstract][Full Text] [Related]
9. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
[TBL] [Abstract][Full Text] [Related]
10. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
[TBL] [Abstract][Full Text] [Related]
11. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.
Kaiser L; Fritz RS; Straus SE; Gubareva L; Hayden FG
J Med Virol; 2001 Jul; 64(3):262-8. PubMed ID: 11424113
[TBL] [Abstract][Full Text] [Related]
12. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
13. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
14. [Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease].
Kolobukhina LV; Merkulova LN; Shchelkanov MIu; Burtseva EI; Lavrishcheva VV; Samokhvalov EI; Al'khovskiĭ SV; Prilipov AG; Proshina ES; Avdeev SN; Sutochnikova OA; Bazarova MV; Kelli EI; Tserukalova ND; Blank IA; Shestakova OM; Kolivashko ON; Arseneva TV; Ambrosi OE; Shul'diakov AA; Popov AF; Simakova AI; Malyshev NA; Chuchalin AG; L'vov DK
Ter Arkh; 2011; 83(9):48-53. PubMed ID: 22145388
[TBL] [Abstract][Full Text] [Related]
15. Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief.
Ishaqui AA; Khan AH; Sulaiman SAS; Alsultan MT; Khan I; Naqvi AA
Expert Rev Respir Med; 2020 May; 14(5):533-541. PubMed ID: 32053044
[No Abstract] [Full Text] [Related]
16. Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients.
Ishaqui AA; Khan AH; Sulaiman SA; Alsultan M; Khan I
Saudi Med J; 2020 Sep; 41(9):1015-1021. PubMed ID: 32893285
[TBL] [Abstract][Full Text] [Related]
17. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
Pizzorno A; Abed Y; Rhéaume C; Boivin G
Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR].
Kiselev OI; Maleev VV; Deeva EG; Leneva IA; Selkova EP; Osipova EA; Obukhov AA; Nadorov SA; Kulikova EV
Ter Arkh; 2015; 87(1):88-96. PubMed ID: 25823275
[TBL] [Abstract][Full Text] [Related]
19. [Monitoring of the sensitivity of epidemic influenza virus strains isolated in Russia to etiotropic chemical agents].
Burtseva EI; Shevchenko ES; Beliakova NV; Oskerko TA; Kolobukhina LV; Merkulova LN; Vartanian RV; Prilipov AG; Rotanov M; Zaplatnikov AL
Vopr Virusol; 2009; 54(5):24-8. PubMed ID: 19882899
[TBL] [Abstract][Full Text] [Related]
20. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice.
Liu B; Bao L; Wang L; Li F; Wen M; Li H; Deng W; Zhang X; Cao B
J Microbiol Immunol Infect; 2021 Jun; 54(3):396-403. PubMed ID: 31780358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
